![Sarah Noonberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Noonberg
Director Técnico/Científico/I+D en METAGENOMI, INC. .
Fortuna: 185 530 $ al 31/05/2025
Cargos activos de Sarah Noonberg
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| METAGENOMI, INC. | Director Técnico/Científico/I+D | 01/01/2023 | - |
Historial de carrera de Sarah Noonberg
Antiguos cargos conocidos de Sarah Noonberg.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 16/05/2023 | 14/11/2024 |
| Independent Dir/Board Member | 16/05/2023 | 14/11/2024 | |
| NEUROGENE INC. | Director/Miembro de la Junta | 01/08/2019 | 01/12/2023 |
| Independent Dir/Board Member | 01/08/2019 | 01/12/2023 | |
| PROTAGONIST THERAPEUTICS, INC. | Director/Miembro de la Junta | 14/12/2017 | 25/05/2023 |
| Independent Dir/Board Member | 14/12/2017 | 25/05/2023 | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes Compass platform, which allows to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 28, 2019 and is headquartered in San Francisco, CA. | Director Técnico/Científico/I+D | 01/09/2020 | 01/09/2022 |
Nohla Therapeutics, Inc.
 Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Director Técnico/Científico/I+D | 01/05/2018 | 01/05/2019 |
| PROTHENA CORPORATION PLC | Director Técnico/Científico/I+D | 16/05/2017 | 01/03/2018 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/08/2015 | 01/03/2017 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Director Técnico/Científico/I+D | 01/01/2004 | 01/01/2007 |
| ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de Sarah Noonberg.
The University of California, San Francisco | Doctorate Degree |
University of California, Berkeley | Doctorate Degree |
Dartmouth College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 15 |
| Irlanda | 2 |
| Canadá | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 6 |
| Director/Board Member | 6 |
| Independent Dir/Board Member | 4 |
Sectorial
| Health Technology | 14 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| METAGENOMI, INC. | Health Technology |
 | Health Technology |
| Empresas privadas | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical firm utilizing sophisticated computational methods. develop and designs de novo protein therapeutics. The company was is headquartered in Seattle, WA. | Health Technology |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA. | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Medivation, Inc. /Old/ | Health Technology |
- Bolsa de valores
- Insiders
- Sarah Noonberg
- Experiencia
